On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are International Federation of Crohns and Ulcerative Colitis Associations's own share of each project, not the project's full budget.
- Horizon Europe€1.5M · 7 projects
- Horizon 2020€85k · 2 projects
Projects
9 EU-funded projects, newest first. Each links to the official record.
- PerPrev-CIDPartner
Personalized disease prediction and prevention in chronic inflammatory disorders
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€143ktheir share - INTERCEPTPartner
Verification and validation of a biomarker panel that identifies individuals at high risk to develop Crohn’s disease allowing INTERCEPTION of full-blown disease development
Horizon Europe · 2025–2029 · Project on CORDIS ↗
€253ktheir share - FIBROTARGETPartner
Validation of novel immunotherapeutic targets against fibrosis in inflammatory bowel diseases
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€303ktheir share - GlycanTriggerPartner
GLYCANS AS MASTER TRIGGERS OF HEALTH TO INTESTINAL INFLAMMATION TRANSITION
Horizon Europe · 2023–2028 · Project on CORDIS ↗
€113ktheir share - METHYLOMICPartner
DNA methylation markers to predict treatment success of biologicals in Crohn’s disease.
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€376ktheir share - miGut-HealthPartner
Personalised blueprint intestinal health
Horizon Europe · 2023–2026 · Project on CORDIS ↗
€136ktheir share - GENEGUTPartner
Oral delivery of encapsulated RNA nanotherapeutics for targeted treatment of ileal Crohn's disease
Horizon Europe · 2022–2026 · Project on CORDIS ↗
€203ktheir share - ImmUniversePartner
Better control and treatment of immune-mediated diseases by exploring the universe of microenvironment imposed tissue signatures and their correlates in liquid biopsies
Horizon 2020 · 2020–2026 · Project on CORDIS ↗
€50ktheir share - IDEA-FASTPartner
Identifying Digital Endpoints to Assess FAtigue, Sleep and acTivities in daily living in Neurodegenerative disorders and Immune-mediated inflammatory diseases
Horizon 2020 · 2019–2026 · Project on CORDIS ↗
€35ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Christian-Albrechts-Universitaet zu KielGermany · 4 shared projects
- Eurice European Research and Project Office GmbHGermany · 4 shared projects
- Stichting Amsterdam UmcNetherlands · 3 shared projects
- Universitatsklinikum Schleswig-HolsteinGermany · 3 shared projects
- The Chancellor, Masters and Scholars of the University of OxfordUnited Kingdom · 2 shared projects
- The Chancellor Masters and Scholars of the University of CambridgeUnited Kingdom · 2 shared projects
- Katholieke Universiteit LeuvenBelgium · 2 shared projects
- Weizmann Institute of ScienceIsrael · 2 shared projects
- Stichting Radboud UniversiteitNetherlands · 2 shared projects
- The University of ManchesterUnited Kingdom · 2 shared projects
- Stichting VuNetherlands · 2 shared projects
- University College Cork - National University of Ireland, CorkIreland · 2 shared projects
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 2 shared projects
- Academisch Ziekenhuis LeidenNetherlands · 2 shared projects
- Vib vzwBelgium · 2 shared projects
- Academisch Ziekenhuis GroningenNetherlands · 2 shared projects
Fields it works in
Research fields recorded on its Horizon projects.
- DNA
- RNA
- biomaterials
- carbohydrates
- data science
- eHealth
- immunology
- immunotherapy
- inflammatory bowel disease
- inflammatory diseases
- machine learning
- nano-materials
- nutrition
- personalized medicine
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships.
